Cardinal Health, headquartered in Dublin, Ohio, employs 48,000 staff and provides customized healthcare solutions, pharmaceuticals, and medical products across various segments globally. Its operations include distribution of branded and generic drugs, and manufacturing medical devices.
CAH has been in the news recently: BofA Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health, Inc. (CAH) and increased the price forecast from $165 to $170. The company also raised its FY25 EPS guidance to $8.15-$8.20 and anticipates FY26 EPS of $9.10-$9.30, while aiming for over $10 billion in adjusted free cash flow.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
